摘要
目的通过对比常规治疗与常规治疗联合匹多莫德治疗儿科呼吸系统反复感染的临床效果,分析匹多莫德的临床应用价值。方法选取2013年1月到2014年1月我院收治的小儿呼吸系统反复感染患儿156例,随机分成实验组(81例)和对照组(75例)。对照组给予常规治疗,实验组在对照组基础上给予匹多莫德治疗。比较两组的临床疗效以及再感染情况。结果实验组患儿的临床总有效率为95.1%,显著高于对照组的80.0%(P<0.05)。实验组患儿上、下呼吸道的感染控制时间、再次感染病程以及再次感染次数均明显小于对照组(P<0.05)。结论匹多莫德治疗儿科呼吸系统反复感染的疗效显著,可减少感染控制时间,缩短再感染病程,减少再感染次数,具有一定的临床应用价值。
Objective To compare the clinical effects of conventional therapy and conventional therapy combined with pidotimod for pediatric repeated respiratory tube infection（RRTI）, in order to analyze the clinical value of pidotimod. Methods 156 RRTI children treated in our hospital from January 2013 to January 2014 were selected and randomly divided into experimental group（81 cases） and control group（75 cases）. The control group was given routine therapy, the experimental group was given pidotimod on the basis of control group. The clinical efficacy and reinfections situations of two groups were compared. Results The total effective rate of experimental group was 95.1%,significantly higher than 80.0% of control group（P〈0.05）. The infection control time, duration and times of reinfections at upper and lower respiratory tube of experimental group were significantly less than those of control group（P〈0.05）. Conclusions Pidotimod has significant efficacy in treatment of pediatric repeated respiratory tube infection, and can reduce the infection control time, reduce the duration and times of reinfections, which has a certain clinical application value.
出处
《临床医学工程》
2016年第2期209-210,共2页
Clinical Medicine & Engineering
关键词
儿科呼吸系统反复感染
匹多莫德
常规治疗
临床效果
Pediatric repeated respiratory infection
Pidotimod
Conventional treatment
Clinical effect
